Rephonic
Artwork for Lung Cancer Update

Lung Cancer Update

Dr. Neil Love
Non-Small Cell Lung Cancer
Lung Cancer
Immunotherapy
Small Cell Lung Cancer
EGFR Mutation
Adora Trial
Alk-Targeted Therapy
Clinical Trials
Biomarkers
Osimertinib
Chemotherapy
Localized Non-Small Cell Lung Cancer
EGFR
Progressive Non-Small Cell Lung Cancer
Allena Trial
Neuroendocrine Tumors
Drug Development
EGFR Mutations
Brain Metastasis
Adjuvant Therapy

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

PublishesTwice monthlyEpisodes359Founded20 years ago
Number of ListenersCategories
ScienceMedicineHealth & Fitness

Listen to this Podcast

Artwork for Lung Cancer Update

Latest Episodes

Dr Justin F Gainor, Dr Corey J Langer and Dr Misty Dawn Shields summarize the treatment landscape and review relevant clinical datasets for patients with lung cancer.

CME information and select publications here.

Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer.

CME information and select publications here.

Dr Aaron Lisberg from the University of California, Los Angeles, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer.

CME information and select publications here.

Dr Aaron Lisberg from the University of California, Los Angeles discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer.

CME information and select publications here.

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Aaron Lisberg
Medical Oncologist at the University of California, Los Angeles
University of California, Los Angeles
Episode: Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Dr. Aaron Lisberg
Medical oncologist from the University of California, Los Angeles
University of California, Los Angeles
Episode: Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Dr. Jacob Sands
Medical oncologist at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Ben Levy
Professor at Johns Hopkins Sidney Kimmel Cancer Center
Johns Hopkins Sidney Kimmel Cancer Center
Episode: Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Dr. Justin Gainor
Medical Oncologist at Massachusetts General Hospital
Massachusetts General Hospital
Episode: First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Dr. Edward Garon
Professor, Director of the Rassica Oncology Program at UCLA
David Geffen School of Medicine
Episode: Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer
Dr. Sarah Goldberg
Medical Oncologist and cancer researcher
Yale Cancer Center
Episode: Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Lung Cancer
Dr. Josh Sabari
Medical Oncologist specializing in thoracic oncology
NYU Lagoon Health and Perlmutter Cancer Center
Episode: Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Lung Cancer
Stephen Liu
Medical oncologist from Georgetown University Hospital
Georgetown University Hospital
Episode: Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences

Host

Dr. Neil Love
Medical Oncologist and Host focusing on lung cancer updates, involved in bridging research and clinical practice.

Reviews

4.6 out of 5 stars from 47 ratings
  • Medicine resident subscriber

    Third year medicine resident applying to Heme onc fellowship. I am interested in lung cancer and this podcast inspires critical thinking about patient management and provokes thought about the lung cancer literature. Uniquely has fantastic interviews with experts in the field. A great listen. I recommend this to anyone interested in oncology and interested in improving their knowledge of lung cancer management.

    Apple Podcasts
    5
    MG2MD
    United States7 years ago
  • Heldere informatie over longkanker

    Hier ben ik heel blij mee.

    Ik wou dat zoiets in het Nederlands bestond.

    Apple Podcasts
    5
    Thea 1953
    Netherlands14 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Feedback expresses gratitude for the expert interviews and insights provided, mentioning the practical applications discussed.
Many recommend the content for its critical perspective on the evolving landscape of lung cancer therapies.
Listeners appreciate the depth and clarity of discussions, often highlighting the importance of staying informed about the latest in lung cancer treatment.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#199
India/Science
Apple Podcasts
#203
Philippines/Science

Talking Points

Recent interactions between the hosts and their guests.

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Q: What are the key toxicities associated with Dato-DXD?
Key toxicities include mucositis, ocular surface toxicity, and interstitial lung disease, each requiring specific management strategies.
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Q: How do you make the decision between whether or not to start systemic therapy right away or do radiation therapy in SVC syndrome?
Dr. Levy discusses the importance of evaluating the patient's histology and typically consults with his radiation oncologist for swift radiation treatment, especially in cases of non-small cell lung cancer.
Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases
Q: How should we be managing Lambert-Eaton Syndrome?
Management should focus on treating the underlying cancer, ideally improving neurological function, though patients may have residual issues.
Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases
Q: Stephen, do you see syndromes like SIADH correlating with tumor status?
Endocrine neoplastic syndromes often correlate well with cancer status and can indicate response to treatment.
EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
Q: Are you discussing all three options with your patients?
Yes, mentioned discussing efficacy and toxicity with patients to decide on the best treatment regimen.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Lung Cancer Update

What is Lung Cancer Update about and what kind of topics does it cover?

Focused on the latest advancements in lung cancer treatment, this series includes in-depth interviews with leading experts in thoracic oncology. Key topics frequently discussed include the role of antibody-drug conjugates, the management of specific lung cancer types like non-small cell lung cancer and small cell lung cancer, and the emerging therapies within these domains. The content aims to bridge research findings with practical patient care, making it a valuable resource for healthcare professionals seeking to enhance their understanding and application of cutting-edge treatment options. Particularly noteworthy is the exploration of clinical trials, treatment protocols, and the impact of new biomarkers on therapy effectiveness.

Where can I find podcast stats for Lung Cancer Update?

Rephonic provides a wide range of podcast stats for Lung Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Lung Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Lung Cancer Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Lung Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Lung Cancer Update?

Rephonic provides comprehensive predictive audience data for Lung Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Lung Cancer Update have?

To see how many followers or subscribers Lung Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Lung Cancer Update?

These podcasts share a similar audience with Lung Cancer Update:

1. Lung Cancer Considered
2. Gastrointestinal Cancer Update
3. Breast Cancer Update
4. Prostate Cancer Update
5. Oncology Today with Dr Neil Love

How many episodes of Lung Cancer Update are there?

Lung Cancer Update launched 20 years ago and published 359 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Lung Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Lung Cancer Update?

Rephonic pulls ratings and reviews for Lung Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Lung Cancer Update?

Rephonic provides full transcripts for episodes of Lung Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Lung Cancer Update?

Recent guests on Lung Cancer Update include:

1. Aaron Lisberg
2. Dr. Aaron Lisberg
3. Dr. Jacob Sands
4. Ben Levy
5. Dr. Justin Gainor
6. Dr. Edward Garon
7. Dr. Sarah Goldberg
8. Dr. Josh Sabari

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days